Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹9.04 Cr₹41 Cr₹-60 Cr₹-73 Cr₹-108 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS is ₹9.04 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹9.04 Cr
Mar2024₹41 Cr
Mar2023₹-60 Cr
Mar2022₹-73 Cr
Mar2021₹-108 Cr

How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹9.04 Cr
-77.74
Mar2024 ₹41 Cr
Positive
Mar2023 ₹-60 Cr
Negative
Mar2022 ₹-73 Cr
Negative
Mar2021 ₹-108 Cr -

Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹26,387.6 Cr -0.4% 5.6% 5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,412.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹170,343.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,191.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹122,511.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,523.0 Cr 2.2% 6.6% 5.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-0.4%

5.6%

5%

SENSEX

0.7%

0.9%

6.1%


You may also like the below Video Courses